{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:03:09Z","timestamp":1790366589978,"version":"4.1.0"},"reference-count":30,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2008,9,5]],"date-time":"2008-09-05T00:00:00Z","timestamp":1220572800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Ophthalmologica"],"published-print":{"date-parts":[[2009,11]]},"abstract":"<jats:title>Abstract.<\/jats:title><jats:p><jats:bold>Purpose:\u2002<\/jats:bold> A number of common eye diseases are associated with ocular perfusion abnormalities. The present study aimed to investigate whether systemically administered moxaverine improves ocular blood flow.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Sixteen healthy volunteers were studied in this randomized, double\u2010masked, placebo\u2010controlled, two\u2010way crossover study. Moxaverine in a dose of 150\u2003mg was administered i.v. Ocular haemodynamic parameters were measured before and after drug administration. Retinal arterial and venous diameters were measured with a retinal vessel analyser. Retinal blood velocity was assessed using laser Doppler velocimetry and choroidal and optic nerve head blood flow was measured with laser Doppler flowmetry.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Moxaverine increased choroidal blood flow (22.6\u2003\u00b1\u200327.9%), an effect which was significant versus placebo (p\u2003=\u20030.015). Red blood cell velocity in retinal veins tended to increase by 13.6\u2003\u00b1\u200313.3% after infusion of moxaverine, but this effect was not significant compared with placebo (p\u2003=\u20030.25). In the optic nerve head moxaverine also tended to increase blood flow (11.8\u2003\u00b1\u200312.7%), but, again, this effect was not significant versus placebo (p\u2003=\u20030.12). Neither moxaverine nor placebo had an effect on retinal arterial diameters. In retinal veins moxaverine tended to induce vasodilation (2.6\u2003\u00b1\u20032.8%) and to increase blood flow (19.6\u2003\u00b1\u200316.5%), but these effects were not significant (both p\u2003=\u20030.12).<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> The present study indicates an increase in choroidal blood flow after systemic infusion of a single dose of moxaverine in healthy subjects. Further studies are warranted to investigate whether these effects are also seen after longterm treatment in patients with ocular vascular disease.<\/jats:p>","DOI":"10.1111\/j.1755-3768.2008.01338.x","type":"journal-article","created":{"date-parts":[[2008,9,5]],"date-time":"2008-09-05T10:03:39Z","timestamp":1220609019000},"page":"731-735","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Effect of systemic moxaverine on ocular blood flow in humans"],"prefix":"10.1111","volume":"87","author":[{"given":"Hemma","family":"Resch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnther","family":"Weigert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Karl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berthold","family":"Pemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Garhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopold","family":"Schmetterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,10,20]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2005.21.210"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2005.21.210"},{"key":"e_1_2_6_4_1","first-page":"288","article-title":"Effects of different phosphodiesterase\u2010inhibiting drugs on human pregnant myometrium: an in vitro study","volume":"290","author":"Berg G","year":"1987","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"e_1_2_6_5_1","first-page":"187","article-title":"Effects of papaverine derivatives on cyclic 3\u2032,5\u2032\u2010AMP phosphodiesterase and relaxation of rabbit ileum","volume":"11","author":"Berndt SF","year":"1974","journal-title":"J Neural Transm"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2006.00780.x"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2006.00780.x"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/1520-7560(0000)9999:9999<::AID-DMRR157>3.0.CO;2-G"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/1520-7560(0000)9999:9999<::AID-DMRR157>3.0.CO;2-G"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0420.2002.800503.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0420.2002.800503.x"},{"key":"e_1_2_6_12_1","first-page":"1131","article-title":"The treatment of cerebrovascular insufficiency. Their evaluation in a double\u2010blind study","volume":"117","author":"Feine\u2010Haake G","year":"1975","journal-title":"MMW Munch Med Wochenschr"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1350-9462(97)00006-2"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1350-9462(97)00006-2"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1350-9462(02)00008-3"},{"key":"e_1_2_6_16_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000310566","article-title":"The influence of magnesium on visual field and peripheral vasospasm in glaucoma","volume":"209","author":"Gaspar AZ","year":"1995","journal-title":"Ophthalmologica"},{"key":"e_1_2_6_17_1","article-title":"Decreases in choroidal circulation precede choroidal neovascularization (CNV) formation and visual loss in age\u2010related macular degeneration (AMD)","volume":"48","author":"Grunwald JE","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02172889"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02172889"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.44.6.603"},{"key":"e_1_2_6_21_1","first-page":"527","article-title":"Ocular effects of topical administration of the phosphodiesterase III inhibitor milrinone in rabbits and cats","volume":"15","author":"Lee KC","year":"1993","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"e_1_2_6_22_1","first-page":"100","article-title":"Infusionsbehandlung diabetischer Stoffwechselst\u00f6rungen des Auges","volume":"161","author":"Lindemann H","year":"1972","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(98)00437-1"},{"key":"e_1_2_6_24_1","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1136\/bjo.84.11.1285","article-title":"Evaluation of the Zeiss retinal vessel analyser","volume":"84","author":"Polak K","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"e_1_2_6_25_1","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1167\/iovs.03-0177","article-title":"Effects of sildenafil on retinal blood flow and flicker\u2010induced retinal vasodilatation in healthy subjects","volume":"44","author":"Polak K","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_6_26_1","first-page":"1124","article-title":"Blood velocity and volumetric flow rate in human retinal vessels","volume":"26","author":"Riva CE","year":"1985","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1350-9462(01)00014-3"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1350-9462(01)00014-3"},{"key":"e_1_2_6_29_1","article-title":"Reduced choroidal blood flow parameters are a risk factor for the development of neovascular AMD","volume":"48","author":"Schmetterer L","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2007.00887.x"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2007.00887.x"}],"container-title":["Acta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1755-3768.2008.01338.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1755-3768.2008.01338.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T14:50:27Z","timestamp":1697035827000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1755-3768.2008.01338.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,20]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["10.1111\/j.1755-3768.2008.01338.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1755-3768.2008.01338.x","archive":["Portico"],"relation":{},"ISSN":["1755-375X","1755-3768"],"issn-type":[{"value":"1755-375X","type":"print"},{"value":"1755-3768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,20]]},"assertion":[{"value":"2009-10-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}